About Debut
Debut Biotech focuses on developing and selling biotechnology solutions that are beneficial for the environment and people. Their products utilize biological processes and systems to create innovations that are climate positive and people positive. This means they aim to produce solutions that not only help businesses in industries like pharmaceuticals, agriculture, and environmental conservation but also contribute positively to the world. Unlike many competitors, Debut Biotech emphasizes a commitment to sustainability and social responsibility in their offerings. The goal of Debut Biotech is to provide effective biotech solutions that align with the values of environmental and social well-being.
San Diego, CaliforniaHeadquarters
2019Year Founded
$64.4MTotal Funding
SERIES_BCompany Stage
Social Impact, BiotechnologyIndustries
51-200Employees
Risks
Economic viability of precision fermentation remains uncertain for large-scale production.
Dependence on L'Oréal for funding may limit strategic flexibility.
Regulatory hurdles could impede bioindustrial manufacturing facility establishment.
Differentiation
Debut integrates biotechnology with brand creation for sustainable wellness solutions.
Their proprietary cell-free biomanufacturing technology unlocks novel activities for personal care brands.
Debut's intrapreneurial model sets a new standard for big business innovation.
Upsides
Partnership with L'Oréal positions Debut as a leader in sustainable fragrance innovation.
$2 million DoD award could lead to $100 million in follow-on funding.
$40 million Series B funding accelerates development of eco-friendly beauty products.
Funding
Total raised$64.39 M
Latest valuation$200.00 M
StageSERIES_B
SERIES B
5/31/2023$40
$200.00 MSERIES A
7/31/2021$23
$113.00 MGRANT
8/31/2020$1
$3
$13.00 M